IPI-926 (Saridegib)

SKU: C-1187-2mg

Quantity (mg):

2 mg

Product Options

Quantity

$563.99

Catalog#: C-1187

Targets: Hedgehog

Synonym: IPI 926; IPI-926; IPI926; Saridegib

Chemical Name/IUPAC:N-((2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3,6,11',12b'-tetramethyl-2',3a,3',4,4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,3H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulen]-3'-yl)methanesulfonamide

Technical Data

Product Name: IPI-926 (Saridegib)

Chemical Formula: C29H48N2O3S

Molecular Weight: 504.76

CAS#: 1037210-93-7

Appearance: Solid powder

Purity: > 99% by HPLC

Solubility: Soluble in DMSO

Storage: Room temperature for months, or -20ºC for 3 years

Description
IPI-926 (Saridegib) is an orally bioavailable inhibitor of the Hedgehog (Hh) pathway with potential antineoplastic activity. Specifically, IPI-926 binds to and inhibits the cell membrane-spanning G-protein coupled receptor SMO, which may result in the suppression of Hh pathway signaling and a decrease in tumor cell proliferation and survival. SMO is activated upon binding of Hh ligand to the cell surface receptor Patched (PTCH); inappropriate activation of Hh signaling and uncontrolled cellular proliferation may be associated with SMO mutations.

IPI-926 (Saridegib)

Related products

A-1210477

ABT-199 (Venectoclax)

ABT-263 (Navitoclax)

ABT-737